CRISPR Therapeutics blueprints cell therapy manufacturing site; Regeneron fights back against kickback claims
→ CRISPR Therapeutics $CRSP is joining the rush to build out a new cell therapy manufacturing space. The biotech reports that it is building a new facility for its R&D and commercial needs in Framingham, MA, with plans to hire up to 100 workers to staff it. Noted CEO Samarth Kulkarni: “We look forward to building a state-of-the-art manufacturing facility, which will accelerate our programs and allow us to scale for commercial supply.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.